Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer
Clinical trial NCT00193206 · COMPLETED
Trial details
- NCT number
- NCT00193206
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2008-10-01
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.